Echocardiography is the standard for assessing LVH in hypertension, and trials evaluating LV mass regression require rigorous design including adequate size, duration of at least 1 year, and randomized double-blind methodology.
No takes yet. Share an insight, caveat, or question.
Supports echocardiography for LVH assessment in hypertension; leaves open whether rigorous trial designs are required for LV mass regression evidence.
Philip R. Liebson (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: